| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.77B | 7.04B | 7.18B | 6.94B | 7.24B | 8.66B |
| Gross Profit | 4.88B | 5.56B | 5.77B | 5.71B | 6.19B | 7.70B |
| EBITDA | 967.55M | 1.25B | 1.38B | 1.55B | 2.09B | 3.32B |
| Net Income | 1.65B | 1.79B | 2.03B | 1.94B | 2.56B | 3.28B |
Balance Sheet | ||||||
| Total Assets | 28.77B | 30.22B | 30.84B | 29.72B | 28.53B | 23.73B |
| Cash, Cash Equivalents and Short-Term Investments | 21.89B | 23.32B | 23.55B | 22.08B | 20.73B | 14.63B |
| Total Debt | 32.09M | 96.71M | 196.14M | 110.39M | 124.78M | 202.71M |
| Total Liabilities | 3.45B | 5.02B | 5.66B | 4.63B | 4.59B | 4.92B |
| Stockholders Equity | 24.07B | 23.95B | 23.93B | 23.89B | 22.62B | 17.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.23B | 2.37B | 2.45B | 3.30B | 3.06B |
| Operating Cash Flow | 0.00 | 1.37B | 2.45B | 2.57B | 3.52B | 3.33B |
| Investing Cash Flow | 0.00 | -3.05B | 1.00B | -3.11B | -3.81B | -2.99B |
| Financing Cash Flow | 0.00 | -1.70B | -1.12B | -1.14B | 2.90B | -546.97M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$196.06B | 13.56 | 25.44% | ― | 11.37% | 16.74% | |
73 Outperform | HK$100.01B | 17.65 | 13.77% | 1.01% | 13.62% | 80.52% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | HK$16.85B | 12.92 | 3.33% | 9.97% | -5.74% | -14.46% | |
60 Neutral | HK$16.62B | 5.39 | 12.13% | 8.13% | -1.40% | 22.37% | |
53 Neutral | HK$287.08B | 59.14 | 2.02% | ― | -2.92% | -57.12% | |
50 Neutral | HK$1.84B | -9.81 | -4.72% | ― | -23.80% | ― |